Historical Stock Price
FOLD historical stock prices picture
Amicus Therapeutics (FOLD) has the following price history information. Looking back at FOLD historical stock prices for the last five trading days, on April 12, 2024, FOLD opened at $11.07, traded as high as $11.07 and as low as $10.56, and closed at $10.68. Trading volume was a total of 2.25M shares. On April 15, 2024, FOLD opened at $10.66, traded as high as $10.81 and as low as $10.59, and closed at $10.66. Trading volume was a total of 2.75M shares. On April 16, 2024, FOLD opened at $10.61, traded as high as $10.72 and as low as $10.49, and closed at $10.56. Trading volume was a total of 2.80M shares. On April 17, 2024, FOLD opened at $10.61, traded as high as $10.66 and as low as $10.48, and closed at $10.55. Trading volume was a total of 3.01M shares. On April 18, 2024, FOLD opened at $10.56, traded as high as $10.59 and as low as $10.32, and closed at $10.33. Trading volume was a total of 1.73M shares.

FOLD Historical Stock Prices By Date:

FOLD historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Amicus Therapeutics shares, starting with a $10,000 purchase of FOLD, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/22/2014
End date: 04/18/2024
Start price/share: $1.88
End price/share: $10.33
Dividends collected/share: $0.00
Total return: 449.47%
Average Annual Total Return: 18.58%
Starting investment: $10,000.00
Ending investment: $54,942.91
Years: 10.00
Date Open High Low Close Volume
04/12/2024 $11.07 $11.07 $10.56 $10.68 2.25M
04/15/2024 $10.66 $10.81 $10.59 $10.66 2.75M
04/16/2024 $10.61 $10.72 $10.49 $10.56 2.80M
04/17/2024 $10.61 $10.66 $10.48 $10.55 3.01M
04/18/2024 $10.56 $10.59 $10.32 $10.33 1.73M
Amicus Therapeutics is a biotechnology company focused on discovering, developing, and delivering medicines for diseases. Co.'s gene therapy portfolio pipeline include Pompe disease, Fabry disease, CDKL5 deficiency disorder, ceroid lipofuscinosis, neuronal, Mucopolysaccharidosis Type IIIB, as well as a program in Mucopolysaccharidosis Type IIIA. Co.'s collaboration with University of Pennsylvania also provides Co. with disease-specific access and option rights to develop new gene therapy platform technologies and programs for most lysosomal disorders and a portfolio of other rare diseases.
Date Close
04/12/2024$10.68
04/15/2024$10.66
04/16/2024$10.56
04/17/2024$10.55
04/18/2024$10.33
FOLD is categorized under the Healthcare sector; below are some other companies in the same sector:

FONR Historical Stock Prices
FPRX Historical Stock Prices
FRX Historical Stock Prices
FURX Historical Stock Prices
FVE Historical Stock Prices
GALE Historical Stock Prices
GALT Historical Stock Prices
GAP Historical Stock Prices
GB Historical Stock Prices
GBIM Historical Stock Prices

Also explore: FOLD shares outstanding history

Email EnvelopeFree FOLD Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


FOLD Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.